GTVI
Joway Health Industries Group Inc. [GTVI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GTVI Stock Summary
In the News
GTVI Financial details
Company Rating
-
Market Cap
15.3M
Income
-1.77M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
21
Optionable
No
Shortable
Yes
Earnings
30 Apr 2023
P/E
-12.79
Forward P/E
-
PEG
-2.23
P/S
-
P/B
-2.76
P/C
-
P/FCF
-26.4
Quick Ratio
0.08
Current Ratio
0.12
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-39.34%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-37.24%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-664%
ROE
44%
ROC
1.7%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0101-0.62
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
786
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 786
- Market Capitalization 15.3M
- Employee 21
- CEO Mr. Steven Zachariah Rudofsky
- Headquarters Las Vegas,NV,US
- IPO Date 2009-09-14
Joway Health Industries Group Inc. does not have significant operations. Previously, it was engaged in the manufacture and sale of tourmaline-related healthcare products. The company is based in Las Vegas, Nevada. Joway Health Industries Group Inc. is a subsidiary of JHP Holdings, Inc.
